World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

RECENT ADVANCES IN THE DIAGNOSIS, TREATMENT, AND CLINICAL MANAGEMENT OF DEEP VEIN THROMBOSIS: A COMPREHENSIVE REVIEW

Mohammed Khalid Abbood, Ali Khalaf Hasan, Zeyad Duraid Najmuldeen and Ahmed Alaa Al-Temimi*

ABSTRACT

A frequent disorder called deep vein thrombosis (DVT) can have fatal consequences such pulmonary embolism, postphlebitic syndrome, and embolism. Over time, the method for diagnosing DVT has changed. These days, a safe and practical method for investigating suspected lower-extremity thrombosis combines compression ultrasound imaging, D-dimer test, & pretest probability into an algorithm strategy. Diagnostic imaging is not necessary to exclude proximal DVT in patients with low pretest likelihood & negative result of D-dimer test. Anticoagulation therapy is the cornerstone of treatment for DVT; thrombolysis and inferior vena cava filter implantation are saved for extreme circumstances. The majority of DVT patients can be managed outpatient with the use of low-molecular-weight heparin. Whether the original event was caused by a transitory risk factor or was idiopathic determines how long anticoagulant medication should be administered. More investigation is needed to identify the best predictors of recurrent DVT in order to identify the patients who will benefit from continued anticoagulant medication.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR